Mar. May 18, 2021

Latino News

Noticias de Hazleton y el mundo

Fundado el 20 de mayo de 2013

Axial Biotherapeutics to Present at The JMP Securities CNS Forum

Axial Biotherapeutics to Present at The JMP Securities CNS Forum

WALTHAM, Mass.–(BUSINESS WIRE)–#autism–Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that management will participate in a fireside chat at The JMP Securities CNS Forum on Wednesday, August 19, 2020 at 2:00 PM ET.

Axial Biotherapeutics to Present at The JMP Securities CNS Forum

About Axial Biotherapeutics

Axial Biotherapeutics is a clinical stage biopharmaceutical company pioneering novel science focused on the interaction between the brain and the gut to mitigate the causes and symptoms of CNS and other gut-derived diseases. The Company has built a pipeline of novel small-molecules and live biotherapeutics with lead programs to address the significant unmet patient needs associated with Parkinson’s Disease and Autism Spectrum Disorder.

Axial Biotherapeutics to Present at The JMP Securities CNS Forum

Contacts

Investor:
David H Donabedian

781-701-8468

david@axialbiotherapeuics.com